Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer

Clinical trial NCT07289282 · RECRUITING

Trial details

NCT number: NCT07289282
Sponsor: Atlas University
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Neoadjuvant Therapy Pathological Response Invasive Breast Carcinoma MicroRNAs

Start date: 2025-12-15
Primary completion: 2026-08-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.